Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Windtree Therapeutics Inc (WINT)  
$0.16 0.00 (0.00%) as of 4:30 Thu 2/23


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 16,920,000
Market Cap: 2.77(M)
Last Volume: 25,688,722 Avg Vol: 24,238,302
52 Week Range: $0.164 - $0.164
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Windtree Therapeutics is a clinical-stage, biopharmaceutical company focused on the development of therapeutics to address unmet medical needs in acute care markets. Co.'s primary product candidate, istaroxime, is a dual-acting agent being developed to improve cardiac function in patients with acute heart failure. In addition, Co. cardiovascular drug product candidates include rostafuroxin, for the treatment of hypertension in patients with a specific genetic profile. Co.'s pulmonary product candidate portfolio consists of a KL4 surfactant platform to address a range of serious respiratory conditions in children and adults.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 2,500 24,812
Total Buy Value $0 $0 $2,250 $15,204
Total People Bought 0 0 1 2
Total Buy Transactions 0 0 1 8
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-03-14 2023-12-12 2023-06-13 2022-06-13

   
Records found: 619
  Page 19 of 25  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Segal Robert-Md Sr VP, Chief Medical Officer   •       –      –    2006-09-30 4 A $1.82 $1,876 D/D 1,033 11,399     -
   Capetola Robert J officerTitle   •       •      –    2006-09-30 4 A $1.82 $1,876 D/D 1,033 493,879     -
   Miller Thomas F SVP, Commercial..& Corp. Dev.   •       –      –    2006-09-30 4 A $1.82 $1,874 D/D 1,032 5,834     -
   Lopez David L Executive VP & Legal Counsel   •       –      –    2006-09-30 4 A $1.82 $1,876 D/D 1,033 22,640     -
   Cooper John G Exec. VP, CFO   •       –      –    2006-09-30 4 A $1.82 $1,876 D/D 1,033 30,400     -
   Cole Kathy Senior VP, Human Resources   •       –      –    2006-09-30 4 A $1.82 $1,874 D/D 1,032 1,032     -
   Mcgowan Kathleen A Director, Finance and   •       –      –    2006-09-30 4 A $1.82 $1,876 D/D 1,033 6,022     -
   Segal Robert-Md Sr VP, Chief Medical Officer   •       –      –    2006-06-30 4 A $2.09 $1,877 D/D 898 10,366     -
   Capetola Robert J President/CEO   •       •      –    2006-06-30 4 A $2.09 $1,879 D/D 899 492,846     -
   Lopez David L Executive VP & Legal Counsel   •       –      –    2006-06-30 4 A $2.09 $1,877 D/D 898 21,607     -
   Cooper John G Exec. VP, CFO   •       –      –    2006-06-30 4 A $2.09 $1,877 D/D 898 29,367     -
   Mcgowan Kathleen A Director, Finance and   •       –      –    2006-06-30 4 A $2.09 $1,877 D/D 898 4,989     -
   Miller Thomas F SVP Commercialization-Corp Dev   •       –      –    2006-06-30 4 A $2.09 $1,043 D/D 499 499     -
   Miller Thomas F SVP, Commercialization & CorpO   •       –      –    2006-06-12 3 IO $0.00 $0 D/D 0 4,303     -
   Capetola Robert J President/CEO   •       •      –    2006-03-31 4 A $7.33 $1,869 D/D 255 491,947     -
   Segal Robert-Md Sr VP, Chief Medical Officer   •       –      –    2006-03-31 4 A $7.33 $1,876 D/D 256 9,468     -
   Lopez David L Executive VP & Legal Counsel   •       –      –    2006-03-31 4 A $7.33 $1,876 D/D 256 20,709     -
   Cooper John G Exec. VP, CFO   •       –      –    2006-03-31 4 A $7.33 $1,876 D/D 256 28,469     -
   Mcgowan Kathleen A Director, Finance and   •       –      –    2006-03-31 4 A $7.33 $1,876 D/D 256 4,091     -
   Segal Robert-Md Sr VP, Chief Medical Officer   •       –      –    2006-01-25 4 A $6.68 $1,743 D/D 261 9,212     -
   Lopez David L Executive VP & Legal Counsel   •       –      –    2006-01-25 4 A $6.68 $1,750 D/D 262 20,453     -
   Cooper John G Exec. VP, CFO   •       –      –    2006-01-25 4 A $6.68 $1,750 D/D 262 28,213     -
   Mcgowan Kathleen A Director, Finance and   •       –      –    2006-01-25 4 A $6.68 $1,743 D/D 261 3,835     -
   Schaber Christopher Exec. VP & COO   •       –      –    2006-01-03 4 A $0.00 $0 D/D 9,000 232,771     -
   Zodda Deni M Phd Sr VP, Business Development   •       –      –    2006-01-03 4 A $0.00 $0 D/D 4,000 11,949     -
  619 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 19 of 25
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us